IL159671A0 - New assays for preimplantation factor and preimplantation factor peptides - Google Patents

New assays for preimplantation factor and preimplantation factor peptides

Info

Publication number: IL159671A0
Authority: IL; Israel
Prior art keywords: pif; present; flow cytometry; binding; peptides
Prior art date: 2001-07-02

Application number

IL15967102A

Other languages

English (en)

Original Assignee

Bioincept Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2002-06-28

Publication date

2004-06-01

2002-06-28 Application filed by Bioincept Inc filed Critical Bioincept Inc

2004-06-01 Publication of IL159671A0 publication Critical patent/IL159671A0/xx

Links

238000003556 assay Methods 0.000 title abstract 3
GLXYOFXNKBTMQL-YKCHQESGSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]butanedioic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O)CCC1 GLXYOFXNKBTMQL-YKCHQESGSA-N 0.000 title 2
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000000684 flow cytometry Methods 0.000 abstract 3
108010022347 proteolysis-inducing peptide Proteins 0.000 abstract 2
238000012286 ELISA Assay Methods 0.000 abstract 1
230000000781 anti-lymphocytic effect Effects 0.000 abstract 1
230000000702 anti-platelet effect Effects 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000004113 cell culture Methods 0.000 abstract 1
230000003833 cell viability Effects 0.000 abstract 1
230000003247 decreasing effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000000758 substrate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70507—C2D

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL15967102A 2001-07-02 2002-06-28 New assays for preimplantation factor and preimplantation factor peptides IL159671A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30260701P	2001-07-02	2001-07-02
PCT/US2002/020599 WO2003004601A2 (fr)	2001-07-02	2002-06-28	Nouveaux dosages pour le facteur preimplantatoire et peptides du facteur preimplantatoire

Publications (1)

Publication Number	Publication Date
IL159671A0 true IL159671A0 (en)	2004-06-01

Family

ID=23168483

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
IL15967102A IL159671A0 (en)	2001-07-02	2002-06-28	New assays for preimplantation factor and preimplantation factor peptides
IL159671A IL159671A (en)	2001-07-02	2003-12-31	Preimplantation factor peptide
IL194710A IL194710A (en)	2001-07-02	2008-10-12	Pre-transplant peptide
IL209472A IL209472A (en)	2001-07-02	2010-11-21	Pre-transplant peptide
IL209481A IL209481A (en)	2001-07-02	2010-11-21	Pre-transplant peptide
IL209509A IL209509A (en)	2001-07-02	2010-11-22	Pre-transplant peptide

Family Applications After (5)

Application Number	Title	Priority Date	Filing Date
IL159671A IL159671A (en)	2001-07-02	2003-12-31	Preimplantation factor peptide
IL194710A IL194710A (en)	2001-07-02	2008-10-12	Pre-transplant peptide
IL209472A IL209472A (en)	2001-07-02	2010-11-21	Pre-transplant peptide
IL209481A IL209481A (en)	2001-07-02	2010-11-21	Pre-transplant peptide
IL209509A IL209509A (en)	2001-07-02	2010-11-22	Pre-transplant peptide

Country Status (12)

Country	Link
US (8)	US7273708B2 (fr)
EP (1)	EP1404877B1 (fr)
JP (1)	JP4593106B2 (fr)
CN (5)	CN102174079B (fr)
AT (1)	ATE454399T1 (fr)
AU (1)	AU2002320198B2 (fr)
CA (1)	CA2490538C (fr)
DE (1)	DE60235011D1 (fr)
IL (6)	IL159671A0 (fr)
MX (1)	MXPA04000151A (fr)
NZ (1)	NZ530723A (fr)
WO (1)	WO2003004601A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4593106B2 (ja)	2001-07-02	2010-12-08	バイオインセプト、エルエルシー	着床前因子の新しいアッセイ方法および着床前因子ペプチド
US8222211B2 (en) *	2001-07-02	2012-07-17	Bioincept, Llc	Methods of administering PIF agonist peptides and uses thereof
ATE516493T1 (de) *	2003-10-22	2011-07-15	Bioincept Llc	Biologische wirkungen von pif-peptiden
US7723289B2 (en)	2003-10-22	2010-05-25	Bioincept, Llc	PIF tetrapeptides
WO2005040196A2 (fr)	2003-10-22	2005-05-06	Bioincept, Llc	Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif
US7723290B2 (en)	2004-10-22	2010-05-25	Bioincept, Llc	Compositions and methods for modulating the immune system
JP6166858B2 (ja)	2011-03-02	2017-07-19	バイオインセプト、エルエルシー	細胞内損傷の治療のための組成物および方法
US9816989B2 (en)	2013-03-12	2017-11-14	Institute of Arthritis Research, LLC	Immunologically active polypeptide
JP2017535794A (ja) *	2014-11-03	2017-11-30	バイオインセプト、エルエルシー	免疫調節不全についてのマーカーとしてのｐｉｆ結合
EP3341739A4 (fr)	2015-08-28	2019-07-10	BioIncept LLC	Peptides mutants et procédés de traitement de sujets les employant
EP3341006A4 (fr)	2015-08-28	2019-03-13	BioIncept LLC	Compositions et méthodes pour le traitement d'une lésion neurologique
WO2018156801A2 (fr) *	2017-02-22	2018-08-30	Bioincept, Llc	Peptides et méthodes de traitement d'affections liées à la dystrophie les utilisant
AU2023356326A1 (en)	2022-10-06	2025-03-27	Bicara Therapeutics Inc.	Multispecific proteins and related methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US564003A (en) *		1896-07-14		chase
US6352694B1 (en) *	1994-06-03	2002-03-05	Genetics Institute, Inc.	Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5279941A (en) *	1992-06-12	1994-01-18	Trustees Of The University Of Pennsylvania	Determination of endometrial receptivity toward embryo implantation
AU5130793A (en) *	1992-09-17	1994-04-12	New York University	Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
US5646003A (en)	1994-03-23	1997-07-08	Barnea; Eytan R.	Preimplantation factor
GB9406492D0 (en)	1994-03-31	1994-05-25	Isis Innovation	Malaria peptides
US6489441B1 (en) *	1995-09-01	2002-12-03	The Salk Institute For Biological Studies	Transcriptional co-repressor that interacts with nuclear hormone receptors
US6585979B1 (en) *	1996-07-08	2003-07-01	Genentech, Inc.	HIV envelope polypeptides and immunogenic composition
US6171591B1 (en) *	1997-12-08	2001-01-09	Pentamer Pharmaceuticals, Inc.	Recombinant nodavirus compositions and methods
US20020004205A1 (en) *	2000-03-30	2002-01-10	Consler Thomas G.	Method of investigating functional molecular interactions and reagents for use therein
JP4191997B2 (ja)	2001-01-04	2008-12-03	ヴァスキュラーバイオジェニックスリミテッド	アテローム性動脈硬化を防止および処置するために斑関連分子を用いる方法および斑関連分子を含有する組成物
US8222211B2 (en) *	2001-07-02	2012-07-17	Bioincept, Llc	Methods of administering PIF agonist peptides and uses thereof
JP4593106B2 (ja)	2001-07-02	2010-12-08	バイオインセプト、エルエルシー	着床前因子の新しいアッセイ方法および着床前因子ペプチド
ES2498371T3 (es)	2002-12-06	2014-09-24	Epimmune Inc.	Antígenos de Plasmodium falciparum y procedimientos de uso
US7156272B2 (en) *	2003-08-22	2007-01-02	Frank Dean	Golf bag carrier for a motorcycle
US7723289B2 (en) *	2003-10-22	2010-05-25	Bioincept, Llc	PIF tetrapeptides
WO2005040196A2 (fr)	2003-10-22	2005-05-06	Bioincept, Llc	Activites biologiques de peptides pif, site d'action, et anticorps pour detecter pif
US7723290B2 (en) *	2004-10-22	2010-05-25	Bioincept, Llc	Compositions and methods for modulating the immune system

2002
- 2002-06-28 JP JP2003510760A patent/JP4593106B2/ja not_active Expired - Fee Related
- 2002-06-28 CN CN201110025233.3A patent/CN102174079B/zh not_active Expired - Fee Related
- 2002-06-28 AT AT02749703T patent/ATE454399T1/de not_active IP Right Cessation
- 2002-06-28 DE DE60235011T patent/DE60235011D1/de not_active Expired - Lifetime
- 2002-06-28 EP EP02749703A patent/EP1404877B1/fr not_active Expired - Lifetime
- 2002-06-28 CA CA2490538A patent/CA2490538C/fr not_active Expired - Lifetime
- 2002-06-28 CN CNA2007100864051A patent/CN101059510A/zh active Pending
- 2002-06-28 CN CN201210307132.XA patent/CN102875646B/zh not_active Expired - Fee Related
- 2002-06-28 IL IL15967102A patent/IL159671A0/xx unknown
- 2002-06-28 CN CNB028133196A patent/CN100339388C/zh not_active Expired - Lifetime
- 2002-06-28 AU AU2002320198A patent/AU2002320198B2/en not_active Expired
- 2002-06-28 WO PCT/US2002/020599 patent/WO2003004601A2/fr not_active Ceased
- 2002-06-28 CN CN201310654136.XA patent/CN103755787B/zh not_active Expired - Fee Related
- 2002-06-28 NZ NZ530723A patent/NZ530723A/en not_active IP Right Cessation
- 2002-06-28 MX MXPA04000151A patent/MXPA04000151A/es active IP Right Grant
- 2002-06-28 US US10/482,244 patent/US7273708B2/en not_active Expired - Lifetime
2003
- 2003-12-31 IL IL159671A patent/IL159671A/en unknown
2007
- 2007-09-14 US US11/855,495 patent/US7670850B2/en not_active Expired - Fee Related
- 2007-09-14 US US11/855,539 patent/US7670851B2/en not_active Expired - Fee Related
- 2007-09-14 US US11/855,519 patent/US7678582B2/en not_active Expired - Fee Related
- 2007-09-14 US US11/855,616 patent/US7695977B2/en not_active Expired - Fee Related
- 2007-09-14 US US11/855,586 patent/US7670852B2/en not_active Expired - Fee Related
2008
- 2008-10-12 IL IL194710A patent/IL194710A/en active IP Right Grant
2010
- 2010-01-26 US US12/693,854 patent/US8012700B2/en not_active Expired - Fee Related
- 2010-11-21 IL IL209472A patent/IL209472A/en not_active IP Right Cessation
- 2010-11-21 IL IL209481A patent/IL209481A/en not_active IP Right Cessation
- 2010-11-22 IL IL209509A patent/IL209509A/en not_active IP Right Cessation
2011
- 2011-08-12 US US13/208,801 patent/US20120009605A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US7695977B2 (en)	2010-04-13
US7273708B2 (en)	2007-09-25
CN100339388C (zh)	2007-09-26
US7670851B2 (en)	2010-03-02
US20120009605A1 (en)	2012-01-12
IL209509A0 (en)	2011-01-31
CA2490538A1 (fr)	2003-01-16
WO2003004601A3 (fr)	2003-12-04
US7670850B2 (en)	2010-03-02
CN103755787B (zh)	2016-05-18
US20080305552A1 (en)	2008-12-11
US20100197040A1 (en)	2010-08-05
CN102174079A (zh)	2011-09-07
CN102174079B (zh)	2013-09-11
IL209472A0 (en)	2011-01-31
DE60235011D1 (de)	2010-02-25
US7678582B2 (en)	2010-03-16
NZ530723A (en)	2006-02-24
US20050064520A1 (en)	2005-03-24
US20080293149A1 (en)	2008-11-27
CN102875646B (zh)	2014-04-16
IL209509A (en)	2012-08-30
IL209481A (en)	2014-02-27
US8012700B2 (en)	2011-09-06
MXPA04000151A (es)	2005-06-06
IL209472A (en)	2014-02-27
JP2005512953A (ja)	2005-05-12
CN101059510A (zh)	2007-10-24
EP1404877B1 (fr)	2010-01-06
CA2490538C (fr)	2011-08-16
AU2002320198B2 (en)	2007-10-04
ATE454399T1 (de)	2010-01-15
CN102875646A (zh)	2013-01-16
CN1522306A (zh)	2004-08-18
JP4593106B2 (ja)	2010-12-08
US20090011427A1 (en)	2009-01-08
IL194710A (en)	2014-06-30
US20080305468A1 (en)	2008-12-11
US7670852B2 (en)	2010-03-02
IL159671A (en)	2010-12-30
CN103755787A (zh)	2014-04-30
EP1404877A4 (fr)	2007-07-11
IL209481A0 (en)	2011-01-31
WO2003004601A2 (fr)	2003-01-16
EP1404877A2 (fr)	2004-04-07
US20080299677A1 (en)	2008-12-04

Publication	Publication Date	Title
IL209509A0 (en)	2011-01-31	Preimplantation factor peptide
WO2006017859A3 (fr)	2006-07-13	Dosages et procedes mettant en oeuvre des biomarqueurs
WO2001049823A3 (fr)	2001-12-20	Dosage pour la detection de bacillus anthracis
WO2004041061A3 (fr)	2005-05-06	Substrats, dispositifs et procedes d'analyses cellulaires
Lee et al.	2009	Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation
EP2455100A3 (fr)	2012-11-07	Réactifs, procédés et systèmes pour la sélection d'un anticorps cytotoxique ou une variante de celui-ci
WO2006124641A3 (fr)	2007-04-12	Anticorps diriges contre la mesotheline utiles pour des dosages immunologiques
MXPA05005288A (es)	2005-08-16	Inmunoanalisis no competitivo para analitos pequenos.
RU2008135060A (ru)	2010-03-10	Применение гликозаминогликанов для снижения неспецифического связывания в иммунологических анализах
RU2006145450A (ru)	2008-06-27	Анализ на антитела
IL180607A0 (en)	2007-06-03	Assays and methods using biomarkers
EP2980586B1 (fr)	2017-08-16	Procédé de test de l'insuline
JP2005512953A5 (fr)	2006-01-19
WO2007001737A3 (fr)	2007-04-12	Procedes et compositions de detection du virus de l'herpes simplex de type 2
WO2020005947A3 (fr)	2020-06-25	Procédés et kits de détection de 11-déshydro-thromboxane b2
Mellody et al.	2025	Multi-reactive hydrogel nanovials for temporal control of secretion capture from antibody-secreting cells
WO2005106494A3 (fr)	2006-06-01	Anticorps monoclonaux, hybridomes, procede ameliore pour la determination de la proteine ptx3 et trousse pour ladite determination
CA2434694A1 (fr)	2002-08-01	Detection et quantification de cripto-1
RU2009139650A (ru)	2011-05-10	Цепь с1 белка 2 промежуточного слоя хряща и его использование для дифференциальной диагностики остеоартрита от ревматоидного артрита и непатологических состояний
WO2008021071A3 (fr)	2008-10-09	Substrats, dispositifs, et procédés pour analyses cellulaires
WO2005020891A3 (fr)	2005-08-04	Anticorps monoclonaux diriges contre la toxine de ricin et procedes de fabrication et d'utilisation desdits anticorps monoclonaux
DE60002466D1 (de)	2003-06-05	Quantifizierungsverfahren für endotheliale mikroteilchen
TR200100643T2 (tr)	2001-07-23	Yüksek-çekimli antikorlar
EP1597579A4 (fr)	2006-06-14	Procede general pour essais d'agglutination de latex
WO2004087747A3 (fr)	2004-11-25	Peptides synthetiques citrullines nouveaux et leurs utilisations